Merck’s WINREVAIR™ (sotatercept-csrk) Met Primary Endpoint in Phase 2 CADENCE Study in Adults With Combined Post- and Precapillary Pulmonary Hypertension (Cp…

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced positive topline results from the ...
The Manila Times

Odyssey Math Tuition Launches JC 2 H2 Math Online Tuition Elearning Course in Singapore, with Plan to Become Singapore's Leading Online Tuition Course Provide…

Odyssey Math Tuition launches JC 2 H2 Math online tuition elearning course in Singapore, featuring a proprietary MOE-aligned ...

Medera Announces First Patient Dosed in Phase 2 Portion of MUSIC-HFrEF Phase 1b/2 Trial Evaluating SRD-001 Gene Therapy for Heart Failure with Reduced Ejection Fraction

Medera Inc. ("Medera"), a clinical-stage biopharmaceutical company focused on targeting cardiovascular diseases by developing next-generation therapeutics, today announced that the first patient has ...

Combination Pill for Heart Failure Improved Heart Function, Symptoms and Quality of Life

Among patients with heart failure and reduced ejection fraction (HFrEF), those taking a "polypill" combination of three ...

Combo pill boosts heart function, symptoms, life quality

Adults with heart failure with reduced ejection fraction (HFrEF) who took a "polypill" combining medications prescribed for ...
Lupus Science & Medicine

Diagnostic implication of left atrial stiffness index in patients with SLE with left ventricular diastolic dysfunction

Objective The left atrial stiffness index (LASI) has been proven to be a promising marker for assessing left atrial (LA) and ...

Eledon Reports Preliminary Data from First Six Patients with Type 1 Diabetes Treated with Tegoprubart as the Core Immunosuppressant Following Islet Transplantation in ...

Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN) today announced preliminary results from an investigator-initiated trial conducted at the University of Chicago Medicine’s Transplant Institute ...